Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Oncol Lett
2017 Aug 01;142:1531-1535. doi: 10.3892/ol.2017.6277.
Show Gene links
Show Anatomy links
Effects of TPX2 gene on radiotherapy sensitization in breast cancer stem cells.
Huang C
,
Han Z
,
Wu D
.
???displayArticle.abstract???
The present study explored the link between the targeting protein for Xenopus kinesin-like protein 2 (TPX2) gene and breast tumor stem cells in order to screen novel radiosensitizers. Expression of TPX2 protein and gene in breast cancer cells was analyzed by western blot analysis and RT-PCR. Three kinds of broad-spectrum sensitizers were selected and their effects on radiotherapy were analyzed by immunohistochemistry in breast tumor stem cells. TPX2 gene and protein were expressed in breast tumor cells and increased gradually along with the expression of cancer cell differentiation; 25 mg/l lovastatin showed best radio-sensitizing effects on breast cancer cells. Furthermore, immunohistochemical results showed that the positive rate of breast cancer cells processed by 25 mg/l lovastatin were significantly decreased. In conclusion, TPX2 gene is closely related to the development of breast cancer stem cells. Moreover, the sensitizing effects of lovastatin on breast tumor stem cells are the result of its influence on the TPX2 gene.
Figure 1. Targeting protein for Xenopus kinesin-like protein 2 (TPX2) expression in different breast cancer cells.
Figure 2. Targeting protein for Xenopus kinesin-like protein 2 (TPX2) mRNA expression in different breast cancer cells.
Figure 3. Targeting protein for Xenopus kinesin-like protein 2 (TPX2) mRNA expression in breast cancer cells at different clinical stages.
Figure 4. Immunohistochemical staining of targeting protein for Xenopus kinesin-like protein 2 (TPX2) in different groups. (A) Immunohistochemical results. TPX2-negative cells are blue; TPX2-positive cells are brown. (B) Counting results of TPX2-positive cells undergoing various processing. *P<0.05, compared with ‘none’ group.
Blanco,
Assessing associations between the AURKA-HMMR-TPX2-TUBG1 functional module and breast cancer risk in BRCA1/2 mutation carriers.
2015, Pubmed
Blanco,
Assessing associations between the AURKA-HMMR-TPX2-TUBG1 functional module and breast cancer risk in BRCA1/2 mutation carriers.
2015,
Pubmed
Cohen,
Posttraumatic growth in breast cancer survivors: a comparison of volunteers and non-volunteers.
2011,
Pubmed
Gürtler,
Stain-Free technology as a normalization tool in Western blot analysis.
2013,
Pubmed
Hsu,
Predictors of exercise frequency in breast cancer survivors in Taiwan.
2011,
Pubmed
Leong,
Is breast cancer the same disease in Asian and Western countries?
2010,
Pubmed
Li,
Distinct expression profiles of Notch-1 protein in human solid tumors: Implications for development of targeted therapeutic monoclonal antibodies.
2010,
Pubmed
Matsuda,
Cancer incidence and incidence rates in Japan in 2004: based on data from 14 population-based cancer registries in the Monitoring of Cancer Incidence in Japan (MCIJ) Project.
2010,
Pubmed
Matsuda,
Cancer incidence and incidence rates in Japan in 2005: based on data from 12 population-based cancer registries in the Monitoring of Cancer Incidence in Japan (MCIJ) project.
2011,
Pubmed
McGuire,
Intervention components promoting adherence to strength training exercise in breast cancer survivors with bone loss.
2011,
Pubmed
Neumayer,
TPX2: of spindle assembly, DNA damage response, and cancer.
2014,
Pubmed
Newlaczyl,
Galectin-3--a jack-of-all-trades in cancer.
2011,
Pubmed
O'Shaughnessy,
Iniparib plus chemotherapy in metastatic triple-negative breast cancer.
2011,
Pubmed
Petry,
Branching microtubule nucleation in Xenopus egg extracts mediated by augmin and TPX2.
2013,
Pubmed
,
Xenbase
Scholz,
Therapeutic plasmid DNA versus siRNA delivery: common and different tasks for synthetic carriers.
2012,
Pubmed
Shimura,
Implication of galectin-3 in Wnt signaling.
2005,
Pubmed
Silva,
Examining the links between perceived impact of breast cancer and psychosocial adjustment: the buffering role of posttraumatic growth.
2012,
Pubmed
Swaminathan,
Cancer survival in Africa, Asia, the Caribbean and Central America: database and attributes.
2011,
Pubmed
Tutt,
Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial.
2010,
Pubmed
Vollebergh,
Genomic instability in breast and ovarian cancers: translation into clinical predictive biomarkers.
2012,
Pubmed
Zorba,
Molecular mechanism of Aurora A kinase autophosphorylation and its allosteric activation by TPX2.
2014,
Pubmed
